CUBIST PHARMACEUTICALS ANNOUNCES REDEMPTION DATE

Cubist Pharmaceuticals, Inc. today announced that it will redeem its 5 1/2% Convertible Subordinates Notes due 2008 on June 28, 2006, in accordance with the terms of the indenture governing the notes. The $165 million principal amount outstanding will be redeemed at $1,032.28 per $1,000 principal amount of notes.
Genetic Engineering News